The Canadian Network for Mood and Anxiety Treatments (Canmat) Task Force Recommendations for the Management of Patients with Mood Disorders and Comorbid Anxiety Disorders

Kennedy SH , Lam RW , Parikh SV , . Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. Introduction. J Affect Disord. 2009;117:S1–S2.

Yatham LN , Kennedy SH , Schaffer A , . Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord. 2009;11:225–255.

American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder, third edition. Arlington, VA: American Psychiatric Publishing Inc.; 2010.

Rakofsky JJ , Dunlop BW. Treating nonspecific anxiety and anxiety disorders in patients with bipolar disorder: a review. J Clin Psychiatry. 2011;72:81–90.

Keck PE Jr , Strawn JR , McElroy SL. Pharmacologic treatment considerations in co-occurring bipolar and anxiety disorders. J Clin Psychiatry. 2006;67:(suppl 1)8–15.

Freeman MP , Freeman SA , McElroy SL. The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology, and treatment issues. J Affect Disord. 2002;68:1–23.

Merikangas KR , Akiskal HS , Angst J , . Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry. 2007;64:543–552.

Schaffer A , Cairney J , Cheung A , . Community survey of bipolar disorder in Canada: lifetime prevalence and illness characteristics. Can J Psychiatry. 2006;51:9–16.

Goldstein BI , Levitt AJ. The specific burden of comorbid anxiety disorders and of substance use disorders in bipolar I disorder. Bipolar Disord. 2008;10:67–78.

Boylan KR , Bieling PJ , Marriott M , . Impact of comorbid anxiety disorders on outcome in a cohort of patients with bipolar disorder. J Clin Psychiatry. 2004;65:1106–1113.

Feske U , Frank E , Mallinger AG , . Anxiety as a correlate of response to the acute treatment of bipolar I disorder. Am J Psychiatry. 2000;157:956–962.

Otto MW , Simon NM , Wisniewski SR , . Prospective 12-month course of bipolar disorder in outpatients with and without comorbid anxiety disorders. Br J Psychiatry. 2006;189:20–25.

Henry C , van den Bulke D , Bellivier F , . Anxiety disorders in 318 bipolar patients: prevalence and impact on illness severity and response to mood stabilizer. J Clin Psychiatry. 2003;64:331–335.

Nakagawa A , Grunebaum MF , Sullivan GM , . Comorbid anxiety in bipolar disorder: does it have an independent effect on suicidality? Bipolar Disord. 2008;10:530–538.

Levander E , Frye MA , McElroy S , . Alcoholism and anxiety in bipolar illness: differential lifetime anxiety comorbidity in bipolar I women with and without alcoholism. J Affect Disord. 2007;101:211–217.

Azorin JM , Kaladjian A , Adida M , . Psychopathological correlates of lifetime anxiety comorbidity in bipolar I patients: findings from a French national cohort. Psychopathology. 2009;42:380–386.

Altshuler LL , Kupka RW , Hellemann G , . Gender and depressive symptoms in 711 patients with bipolar disorder evaluated prospectively in the Stanley Foundation bipolar treatment outcome network. Am J Psychiatry. 2010;167:708–715.

Nery-Fernandes F , Quarantini LC , Galvão- De-Almeida A , . Lower rates of comorbidities in euthymic bipolar patients. World J Biol Psychiatry. 2009;10:474–479.

Gao K , Tolliver BK , Kemp DE , . Differential interactions between comorbid anxiety disorders and substance use disorder in rapid cycling bipolar I or II disorder. J Affect Disord. 2008;110:167–173.

Schaffer A , Cairney J , Veldhuizen S , . Comparison of antidepressant use between subjects with bipolar disorder and major depressive disorder with or without comorbid anxiety. J Clin Psychiatry. 2007;68:1785–1792.

El-Mallakh RS , Hollifield M. Comorbid anxiety in bipolar disorder alters treatment and prognosis. Psychiatr Q. 2008;79:139–150.

Lee JH , Dunner DL. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders. Depress Anxiety. 2008;25:91–97.

Albert U , Rosso G , Maina G , . Impact of anxiety disorder comorbidity on quality of life in euthymic bipolar disorder patients: differences between bipolar I and II subtypes. J Affect Disord. 2008;105:297–303.

Kauer-Sant'Anna M , Frey BN , Andreazza AC , . Anxiety comorbidity and quality of life in bipolar disorder patients. Can J Psychiatry. 2007;52:175–181.

Perlis RH , Miyahara S , Marangell LB , . Longterm implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry. 2004;55:875–881.

Perlis RH , Ostacher MJ , Miklowitz DJ , . Clinical features associated with poor pharmacologic adherence in bipolar disorder: results from the STEP-BD study. J Clin Psychiatry. 2010;71:296–303.

Coryell W , Solomon DA , Fiedorowicz JG , . Anxiety and outcome in bipolar disorder. Am J Psychiatry. 2009;166:1238–1243.

Watson HJ , Swan A , Nathan PR. Psychiatric diagnosis and quality of life: the additional burden of psychiatric comorbidity. Compr Psychiatry. 2011;52:265–272. -

Ibilo?lu AO , Cayköylü A. Distinctive sociodemographic, clinical and temperament characteristics of bipolar-I, bipolar-II and major depressive disorders. Turk Psikiyatri Derg. 2011;22:159–165.

Simon NM , Pollack MH , Ostacher MJ , . Understanding the link between anxiety symptoms and suicidal ideation and behaviors in outpatients with bipolar disorder. J Affect Disord. 2007;97:91–99.

Simon NM , Otto MW , Wisniewski SR , . Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry. 2004;161:2222–2229.

Fagiolini A , Frank E , Rucci P , . Mood and anxiety spectrum as a means to identify clinically relevant subtypes of bipolar I disorder. Bipolar Disord. 2007;9:462–467.

Akiskal HS , Akiskal KK , Perugi G , . Bipolar II and anxious reactive “comorbidity”: toward better phenotypic characterization suitable for genotyping. J Affect Disord. 2006;96:239–247.

Fawcett J. DSM-V perspectives on classification of bipolar disorders. In: Yatham LN , Maj M , eds. Bipolar disorder: clinical and neurobiological foundations. Hoboken, NJ: Wiley Blackwell; 2010:44–51.

Perugi G , Akiskal HS , Toni C , . The temporal relationship between anxiety disorders and (hypo) mania: a retrospective examination of 63 panic, social phobic and obsessive-compulsive patients with comorbid bipolar disorder. J Affect Disord. 2001;67:199–206.

Duffy A , Alda M , Hajek T , . Early stages in the development of bipolar disorder. J Affect Disord. 2010;121:127–135.

Dilsaver SC , Benazzi F , Akiskal KK , . Differential patterns of lifetime multiple anxiety disorder comorbidity between Latino adults with bipolar I and major depressive disorders. Bull Menninger Clin. 2008;72:130–148.

Bauer M , Berman SM , Schlagenhauf F , . Regional cerebral glucose metabolism and anxiety symptoms in bipolar depression: effects of levothyroxine. Psychiatry Res. 2010;181:71–76.

Osuch EA , Ketter TA , Kimbrell TA , . Regional cerebral metabolism associated with anxiety symptoms in affective disorder patients. Biol Psychiatry. 2000;48:1020–1023.

Gaudiano BA , Miller IW. Anxiety disorder comorbidity in bipolar I disorder: relationship to depression severity and treatment outcome. Depress Anxiety. 2005;21:71–77.

Maina G , Albert U , Rosso G , . Olanzapine or lamotrigine addition to lithium in remitted bipolar disorder patients with anxiety disorder comorbidity: a randomized, single-blind, pilot study. J Clin Psychiatry. 2008;69:609–616.

Sheehan DV , McElroy SL , Harnett-Sheehan K , . Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety. J Affect Disord. 2009;115:376–385.

Hirschfeld RM , Weisler RH , Raines SR , . Quetiapine in the treatment of anxiety in patients with bipolar I or II depression: a secondary analysis from a randomized, double-blind, placebo-controlled study. J Clin Psychiatry. 2006;67:355–362.

McElroy SL , Weisler RH , Chang W , . A doubleblind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II). J Clin Psychiatry. 2010;71:163–174.

Young AH , McElroy SL , Bauer M , . A doubleblind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I). J Clin Psychiatry. 2010;71:150–162.

Tohen M , Calabrese J , Vieta E , . Effect of comorbid anxiety on treatment response in bipolar depression. J Affect Disord. 2007;104:137–146.

Sagman D , Lee B , Chandresena R , . Canadian A naturalistic study of a community-based cohort treated for bipolar disorder. BMC Psychiatry. 2010;10:24.

Perugi G , Toni C , Frare F , . Effectiveness of adjunctive gabapentin in resistant bipolar disorder: is it due to anxious-alcohol abuse comorbidity? J Clin Psychopharmacol. 2002;22:584–591.

Davis LL , Bartolucci A , Petty F. Divalproex in the treatment of bipolar depression: a placebo-controlled study. J Affect Disord. 2005;85:259–266.

Calabrese JR , Delucchi GA. Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder. Am J Psychiatry. 1990;147:431–434.

Vieta E , Martinez-Aran A , Nieto E , . Adjunctive gabapentin treatment of bipolar disorder. Eur Psychiatry. 2000;15:433–437.

Vieta E , Cruz N , Garcia-Campayo J , . A doubleblind, randomized, placebo-controlled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder. Int J Neuropsychopharmacol. 2008;11:445–452.

Passmore MJ , Garnham J , Duffy A , . Phenotypic spectra of bipolar disorder in responders to lithium versus lamotrigine. Bipolar Disord. 2003;5:110–114.

Young LT , Cooke RG , Robb JC , . Anxious and non-anxious bipolar disorder. J Affect Disord. 1993;29:49–52.

Leverich GS , Altshuler LL , Frye MA , . Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. Am J Psychiatry. 2006;163:232–239.

Gijsman HJ , Geddes JR , Rendell JM , . Antidepressants for bipolar depression: a systematic review of randomized, controlled trials. Am J Psychiatry. 2004;161:1537–1547.

Sachs GS , Nierenberg AA , Calabrese JR , . Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med. 2007;356:1711–1722.

Simon NM , Otto MW , Weiss RD , . Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD. J Clin Psychopharmacol. 2004;24:512–520.

Chen YW , Dilsaver SC. Comorbidity of panic disorder in bipolar illness: evidence from the Epidemiologic Catchment Area Survey. Am J Psychiatry. 1995;152:280–282.

Magalhaes PV Kapczinski NS , Kapczinski F. Correlates and impact of obsessive-compulsive comorbidity in bipolar disorder. Compr Psychiatry. 2010;51:353–356.

Koyuncu A , Tükel R , Ozyildirim I , . Impact of obsessive-compulsive disorder comorbidity on the sociodemographic and clinical features of patients with bipolar disorder. Compr Psychiatry. 2010;51:293–297.

Maina G , Albert U , Pessina E , . Bipolar obsessive-compulsive disorder and personality disorders. Bipolar Disord. 2007;9:722–729.

McElroy SL , Altshuler LL , Suppes T , . Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry. 2001;158:420–426.

Krüger S , Cooke RG , Hasey GM , . Comorbidity of obsessive compulsive disorder in bipolar disorder. J Affect Disord. 1995;34:117–120.

Krüger S , Bräunig P , Cooke RG. Comorbidity of obsessive-compulsive disorder in recovered inpatients with bipolar disorder. Bipolar Disord. 2000;2:71–74.

Ruscio AM , Stein DJ , Chiu WT , . The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry. 2010;15:53–63.

Pashinian A , Faragian S , Levi A , . Obsessivecompulsive disorder in bipolar disorder patients with first manic episode. J Affect Disord. 2006;94:151–156.

Issler CK , Amaral JA , Tamada RS , . Clinical expression of obsessive-compulsive disorder in women with bipolar disorder. Rev Bras Psiquiatr. 2005;27:139–142.

Baldessarini RJ , Perry R , Pike J. Factors associated with treatment nonadherence among US bipolar disorder patients. Hum Psychopharmacol. 2008;23:95–105.

Perugi G , Akiskal HS , Pfanner C , . The clinical impact of bipolar and unipolar affective comorbidity on obsessive-compulsive disorder. J Affect Disord. 1997;46:15–23.

Raja M , Azzoni A. Clinical management of obsessive-compulsive-bipolar comorbidity: a case series. Bipolar Disord. 2004;6:264–270.

Bisol LW , Lara DR. Improvement of obsessive-compulsive disorder with divalproex and lamotrigine in two patients with bipolar II disorder. Pharmacopsychiatry. 2009;42:37–39.

Marazziti D , Pfanner C , Dell'Osso B , . Augmentation strategy with olanzapine in resistant obsessive compulsive disorder: an Italian long-term open-label study. J Psychopharmacol. 2005;19:392–394.

Petrikis P , Andreou C , Bozikas VP , . Effective use of olanzapine for obsessive-compulsive symptoms in a patient with bipolar disorder. Can J Psychiatry. 2004;49:572–573.

Jacobsen FM. Risperidone in the treatment of affective illness and obsessive-compulsive disorder. J Clin Psychiatry. 1995;56:423–429.

Pfanner C , Marazziti D , Dell'Osso L , . Risperidone augmentation in refractory obsessivecompulsive disorder: an open-label study. Int Clin Psychopharmacol. 2000;15:297–301.

Gao K , Muzina D , Gajwani P , . Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review. J Clin Psychiatry. 2006;67:1327–1340.

Uguz F. Successful treatment of comorbid obsessive-compulsive disorder with aripiprazole in three patients with bipolar disorder. Gen Hosp Psychiatry. 2010;32:556–558.

Perugi G , Toni C , Frare F , . Obsessivecompulsive-bipolar comorbidity: a systematic exploration of clinical features and treatment outcome. J Clin Psychiatry. 2002;63:1129–1134.

Masi G , Toni C , Perugi G , . Anxiety disorders in children and adolescents with bipolar disorder: a neglected comorbidity. Can J Psychiatry. 2001;46:797–802.

MacKinnon DF , Zandi PP , Cooper J , . Comorbid bipolar disorder and panic disorder in families with a high prevalence of bipolar disorder. Am J Psychiatry. 2002;159:30–35.

Goodwin RD , Hoven CW. Bipolar-panic comorbidity in the general population: prevalence and associated morbidity. J Affect Disord. 2002;70:27–33.

Forty L , Smith D , Jones L , . Clinical characteristics of unipolar disorder and bipolar disorder according to the lifetime presence of recurrent panic attacks. Bipolar Disord. 2009;11:307–315.

Frank E , Cyranowski JM , Rucci P , . Clinical significance of lifetime panic spectrum symptoms in the treatment of patients with bipolar I disorder. Arch Gen Psychiatry. 2002;59:905–911.

MacKinnon DF , Zandi PP , Gershon ES , . Association of rapid mood switching with panic disorder and familial panic risk in familial bipolar disorder. Am J Psychiatry. 2003;160:1696–1698.

Toniolo RA , Caetano SC , da Silva PV , . Clinical significance of lifetime panic disorder in the course of bipolar disorder type I. Compr Psychiatry. 2009;50:9–12.

Mula M , Pini S , Monteleone P , . Different temperament and character dimensions correlate with panic disorder comorbidity in bipolar disorder and unipolar depression. J Anxiety Disord. 2008;22:1421–1426.

Dilsaver SC , Chen YW. Social phobia, panic disorder and suicidality in subjects with pure and depressive mania. J Affect Disord. 2003;77:173–177.

Kilbane EJ , Gokbayrak NS , Galynker I , . A review of panic and suicide in bipolar disorder: does comorbidity increase risk? J Affect Disord. 2009;115:1–10.

Rotondo A , Mazzanti C , Dell'Osso L , . Catechol o-methyltransferase, serotonin transporter, and tryptophan hydroxylase gene polymorphisms in bipolar disorder patients with and without comorbid panic disorder. Am J Psychiatry. 2002;159:23–29.

Cheng R , Juo SH , Loth JE , . Genome-wide linkage scan in a large bipolar disorder sample from the National Institute of Mental Health genetics initiative suggests putative loci for bipolar disorder, psychosis, suicide, and panic disorder. Mol Psychiatry. 2006;11:252–260.

Doughty CJ , Wells JE , Joyce PR , . Bipolar-panic disorder comorbidity within bipolar disorder families: a study of siblings. Bipolar Disord. 2004;6:245–252.

MacKinnon DF , Zamoiski R. Panic comorbidity with bipolar disorder: what is the manic-panic connection? Bipolar Disord. 2006;8:648–664.

MacKinnon DF , Craighead B , Hoehn-Saric R. Carbon dioxide provocation of anxiety and respiratory response in bipolar disorder. J Affect Disord. 2007;99:45–49.

Simon NM , Otto MW , Fischmann D , . Panic disorder and bipolar disorder: anxiety sensitivity as a potential mediator of panic during manic states. J Affect Disord. 2005;87:101–105.

Perugi G , Frare F , Toni C , . Adjunctive valproate in panic disorder patients with comorbid bipolar disorder or otherwise resistant to standard antidepressants: a 3-year “open” follow-up study. Eur Arch Psychiatry Clin Neurosci. 2010;260:553–560.

Baetz M , Bowen RC. Efficacy of divalproex sodium in patients with panic disorder and mood instability who have not responded to conventional therapy. Can J Psychiatry. 1998;43:73–77.

Sepede G , Gambi F , Onofrj M , . Olanzapine enhances anxiety response to an SSRI in a woman with bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35:303–304.

Otto MW , Perlman CA , Wernicke R , . Posttraumatic stress disorder in patients with bipolar disorder: a review of prevalence, correlates, and treatment strategies. Bipolar Disord. 2004;6:470–479.

Baldassano CF , Marangell LB , Gyulai L , . Gender differences in bipolar disorder: retrospective data from the first 500 STEP-BD participants. Bipolar Disord. 2005;7:465–470.

Kennedy BL , Dhaliwal N , Pedley L , . Posttraumatic stress disorder in subjects with schizophrenia and bipolar disorder. J Ky Med Assoc. 2002;100:395–399.

Brown GR , McBride L , Bauer MS , . Impact of childhood abuse on the course of bipolar disorder: a replication study in U. S. veterans. J Affect Disord. 2005;89:57–67.

Romero S , Birmaher B , Axelson D , . Prevalence and correlates of physical and sexual abuse in children and adolescents with bipolar disorder. J Affect Disord. 2009;112:144–150.

Goldstein TR , Birmaher B , Axelson D , . History of suicide attempts in pediatric bipolar disorder: factors associated with increased risk. Bipolar Disord. 2005;7:525–535.

Leverich GS , McElroy SL , Suppes T , . Early physical and sexual abuse associated with an adverse course of bipolar illness. Biol Psychiatry. 2002;51:288–297.

Neria Y , Bromet EJ , Sievers S , . Trauma exposure and posttraumatic stress disorder in psychosis: findings from a first-admission cohort. J Consult Clin Psychol. 2002;70:246–251.

Axelson D , Birmaher B , Strober M , . Phenomenology of children and adolescents with bipolar spectrum disorders. Arch Gen Psychiatry. 2006;63:1139–1148.

Findling RL , Gracious BL , McNamara NK , . Rapid, continuous cycling and psychiatric co-morbidity in pediatric bipolar I disorder. Bipolar Disord. 2001;3:202–210.

Biederman J , Faraone SV , Wozniak J , . Clinical correlates of bipolar disorder in a large, referred sample of children and adolescents. J Psychiatr Res. 2005;39:611–622.

Geller B , Tillman R , Craney JL , . Four-year prospective outcome and natural history of mania in children with a prepubertal and early adolescent bipolar disorder phenotype. Arch Gen Psychiatry. 2004;61:459–467.

Dickstein DP , Rich BA , Binstock AB , . Comorbid anxiety in phenotypes of pediatric bipolar disorder. J Child Adolesc Psychopharmacol. 2005;15:534–548.

Sala R , Axelson DA , Castro-Fornieles J , . Comorbid anxiety in children and adolescents with bipolar spectrum disorders: prevalence and clinical correlates. J Clin Psychiatry. 2010;71:1344–1350.

Brotman MA , Rich BA , Schmajuk M , . Attention bias to threat faces in children with bipolar disorder and comorbid lifetime anxiety disorders. Biol Psychiatry. 2007;61:819–821.

Simeonova DI , Jackson V , Attalla A , . Subcortical volumetric correlates of anxiety in familial pediatric bipolar disorder: a preliminary investigation. Psychiatry Res. 2009;173:113–120.

DelBello MP , Hanseman D , Adler CM , . Twelvemonth outcome of adolescents with bipolar disorder following first hospitalization for a manic or mixed episode. Am J Psychiatry. 2007;164:582–590.

Joshi G , Mick E , Wozniak J , . Impact of obsessive-compulsive disorder on the antimanic response to olanzapine therapy in youth with bipolar disorder. Bipolar Disord. 2010;12:196–204.

Masi G , Perugi G , Millepiedi S , . Pharmacological response in juvenile bipolar disorder subtypes: a naturalistic retrospective examination. Psychiatry Res. 2010;177:(1-2)192–198.

Masi G , Perugi G , Toni C , . Obsessivecompulsive bipolar comorbidity: focus on children and adolescents. J Affect Disord. 2004;78:175–183.

Faedda GL , Baldessarini RJ , Glovinsky IP , . Treatment-emergent mania in pediatric bipolar disorder: a retrospective case review. J Affect Disord. 2004;82:149–158.

Kowatch RA , Fristad M , Birmaher B , . Treatment guidelines for children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2005;44:213–235.

Goldstein BI , Levitt AJ. Prevalence and correlates of bipolar I disorder among adults with primary youth-onset anxiety disorders. J Affect Disord. 2007;103:187–195.

Goldstein BI , Shamseddeen W , Axelson DA , . Clinical, demographic, and familial correlates of bipolar spectrum disorders among offspring of parents with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2010;49:388–396.

Walkup JT , Albano AM , Piacentini J , . Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. N Engl J Med. 2008;359:2753–2766.

Wozniak J , Biederman J , Monuteaux MC , . Parsing the comorbidity between bipolar disorder and anxiety disorders: a familial risk analysis. J Child Adolesc Psychopharmacol. 2002;12:101–111.

Kessler RC , Gruber M , Hettema JM , . Co-morbid major depression and generalized anxiety disorders in the National Comorbidity Survey follow-up. Psychol Med. 2008;38:365–374.

Patten SB , Gordon-Brown L , Meadows G. Simulation studies of age-specific lifetime major depression prevalence. BMC Psychiatry. 2010;10:85.

Andrade L , Caraveo-Anduaga JJ , Berglund P , . The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) Surveys. Int J Methods Psychiatr Res. 2003;12:3–21.

Gwynn RC , McQuistion HL , McVeigh KH , . Prevalence, diagnosis, and treatment of depression and generalized anxiety disorder in a diverse urban community. Psychiatr Serv. 2008;59:641–647.

Keller MB , Lavori PW , Wunder J , . Chronic course of anxiety disorders in children and adolescents. J Am Acad Child Adolesc Psychiatry. 1992;31:595–599.

Keller MB. Prevalence and impact of comorbid anxiety and bipolar disorder. J Clin Psychiatry. 2006;67:5–7.

Piccinelli M , Wilkinson G. Outcome of depression in psychiatric settings. Br J Psychiatry. 1994;164:297–304.

Pollack MH , Otto MW. Long-term course and outcome of panic disorder. J Clin Psychiatry. 1997;58:57–60.

Spijker J , de Graaf R , Bijl RV , . Duration of major depressive episodes in the general population: results from The Netherlands Mental Health Survey and Incidence Study (NEMESIS). Br J Psychiatry. 2002;181:208–213.

Vollrath M , Angst J. Outcome of panic and depression in a seven-year follow-up: results of the Zurich study. Acta Psychiatr Scand. 1989;80:591–596.

Bijl RV , Ravelli A. Current and residual functional disability associated with psychopathology: findings from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Psychol Med. 2000;30:657–668.

Hecht H , von Zerssen D , Wittchen HU. Anxiety and depression in a community sample: the influence of comorbidity on social functioning. J Affect Disord. 1990;18:137–144.

Roy-Byrne PP , Stang P , Wittchen HU , . Lifetime panic-depression comorbidity in the National Comorbidity Survey. Association with symptoms, impairment, course and help-seeking. Br J Psychiatry. 2000;176:229–235.

Bruce SE , Yonkers KA , Otto MW , . Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study. Am J Psychiatry. 2005;162:1179–1187.

Brown C , Schulberg HC , Madonia MJ , . Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders. Am J Psychiatry. 1996;153:1293–1300.

Ninan PT , Berger J. Symptomatic and syndromal anxiety and depression. Depress Anxiety. 2001;14:79–85.

Fava M , Rush AJ , Alpert JE , . Difference in treatment outcome in outpatients with anxious versus non- anxious depression: a STAR*D report. Am J Psychiatry. 2008;165:342–351.

Sonawalla SB , Spillmann MK , Kolsky AR , . Efficacy of fluvoxamine in the treatment of major depression with comorbid anxiety disorders. J Clin Psychiatry. 1999;60:580–583.

Hoehn-Saric R , Ninan P , Black DW , . Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders. Arch Gen Psychiatry. 2000;57:76–82.

Fava M , Rosenbaum JF , Hoog SL , . Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression. J Affect Disord. 2000;59:119–126.

Russell JM , Koran LM , Rush J , . Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression. Depress Anxiety. 2001;13:18–27.

Tollefson GD , Holman SL , Sayler ME , . Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features. J Clin Psychiatry. 1994;55:50–59.

Panzer MJ. Are SSRIs really more effective for anxious depression? Ann Clin Psychiatry. 2005;17:23–29.

Lam RW , Kennedy SH , Grigoriadis S , . Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy. J Affect Disord. 2009;117:S26–S43.

Lepola U , Arato M , Zhu Y , . Sertraline versus imipramine treatment of comorbid panic disorder and major depressive disorder. J Clin Psychiatry. 2003;64:654–662.

Canadian Psychiatric Association. Clinical practice guidelines. Management of anxiety disorders. Can J Psychiatry. 2006;51:9S-91S.

Breslau N , Davis GC , Andreski P , . Traumatic events and posttraumatic stress disorder in an urban population of young adults. Arch Gen Psychiatry. 1991;48:216–222.

Creamer M , Burgess P , McFarlane AC. Posttraumatic stress disorder: findings from the Australian National Survey of Mental Health and Well-being. Psychol Med. 2001;31:1237–1247.

Keane TM , Kaloupek DG. Comorbid psychiatric disorders in PTSD. Implications for research. Ann N Acad Y Sci. 1997;821:24–34.

Forbes D , Creamer M , Hawthorne G , . Comorbidity as a predictor of symptom change after treatment in combat-related posttraumatic stress disorder. J Nerv Ment Dis. 2003;191:93–99.

Gradus JL , Qin P , Lincoln AK , . Posttraumatic stress disorder and completed suicide. Am J Epidemiol. 2010;171:721–727.

Kessler RC , Sonnega A , Bromet E , . Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry. 1995;52:1048–1060.

Ginzburg K. Comorbidity of PTSD and depression following myocardial infarction. J Affect Disord. 2006;94:135–143.

Mollica RF , McInnes K , Sarajli? N , . Disability associated with psychiatric comorbidity and health status in Bosnian refugees living in Croatia. JAMA. 1999;282:433–439.

Salcioglu E , Basoglu M , Livanou M. Long-term psychological outcome for non-treatment-seeking earthquake survivors in Turkey. J Nerv Ment Dis. 2003;191:154–160.

Sundquist K , Johansson LM , DeMarinis V , . Posttraumatic stress disorder and psychiatric co-morbidity: symptoms in a random sample of female Bosnian refugees. Eur Psychiatry. 2005;20:158–164.

Hashemian F , Khoshnood K , Desai MM , . Anxiety, depression, and posttraumatic stress in Iranian survivors of chemical warfare. JAMA. 2006;296:560–566.

Zayfert C , Becker CB , Unger DL , . Comorbid anxiety disorders in civilians seeking treatment for posttraumatic stress disorder. J Trauma Stress. 2002;15:31–38.

Mayou R , Bryant B , Ehlers A. Prediction of psychological outcomes one year after a motor vehicle accident. Am J Psychiatry. 2001;158:1231–1238.

McFarlane AC , Papay P. Multiple diagnoses in posttraumatic stress disorder in the victims of a natural disaster. J Nerv Ment Dis. 1992;180:498–504.

Brady KT , Clary CM. Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline. Compr Psychiatry. 2003;44:360–369.

Ginzburg K , Ein-Dor T , Solomon Z. Comorbidity of posttraumatic stress disorder, anxiety and depression: a 20-year longitudinal study of war veterans. J Affect Disord. 2010;123:249–257.

Maes M , Mylle J , Delmeire L , . Psychiatric morbidity and comorbidity following accidental man-made traumatic events: incidence and risk factors. Eur Arch Psychiatry Clin Neurosci. 2000;250:156–162.

Momartin S , Silove D , Manicavasagar V , . Comorbidity of PTSD and depression: associations with trauma exposure, symptom severity and functional impairment in Bosnian refugees resettled in Australia. J Affect Disord. 2004;80:231–238.

Woodward SH , Friedman MJ , Bliwise DL. Sleep and depression in combat-related PTSD inpatients. Biol Psychiatry. 1996;39:182–192.

Merikangas KR , Ames M , Cui L , . The impact of comorbidity of mental and physical conditions on role disability in the US adult household population. Arch Gen Psychiatry. 2007;64:1180–1188.

Sareen J , Houlahan T , Cox BJ , . Anxiety disorders associated with suicidal ideation and suicide attempts in the National Comorbidity Survey. J Nerv Ment Dis. 2005;193:450–454.

Sareen J , Cox BJ , Stein MB , . Physical and mental comorbidity, disability, and suicidal behavior associated with posttraumatic stress disorder in a large community sample. Psychosom Med. 2007;69:242–248.

Oquendo MA , Friend JM , Halberstam B , . Association of comorbid posttraumatic stress disorder and major depression with greater risk for suicidal behavior. Am J Psychiatry. 2003;160:580–582.

Southwick SM , Vythilingam M , Charney DS. The psychobiology of depression and resilience to stress: implications for prevention and treatment. Annu Rev Clin Psychol. 2005;1:255–291.

Airan RD , Meltzer LA , Roy M , . High-speed imaging reveals neurophysiological links to behavior in an animal model of depression. Science. 2007; 317:819–823.

David DJ , Samuels BA , Rainer Q , . Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron. 2009;62:479–493.

Banasr M , Duman RS. Regulation of neurogenesis and gliogenesis by stress and antidepressant treatment. CNS Neurol Disord Drug Targets. 2007;6:311–320.

Feldmann RE Jr , Sawa A , Seidler GH. Causality of stem cell based neurogenesis and depression—to be or not to be, is that the question? J Psychiatr Res. 2007;41:713–723.

Perera TD , Park S , Nemirovskaya Y. Cognitive role of neurogenesis in depression and antidepressant treatment. Neuroscientist. 2008;14:326–338.

Schloesser RJ , Manji HK , Martinowich K. Suppression of adult neurogenesis leads to an increased hypothalamo-pituitary-adrenal axis response. Neuroreport. 2009;20:553–557.

Thomas RM , Peterson DA. Even neural stem cells get the blues: evidence for a molecular link between modulation of adult neurogenesis and depression. Gene Expr. 2008;14:183–193.

Vollmayr B , Mahlstedt MM , Henn FA. Neurogenesis and depression: what animal models tell us about the link. Eur Arch Psychiatry Clin Neurosci. 2007;257:300–303.

Wang JW , David DJ , Monckton JE , . Chronic fluoxetine stimulates maturation and synaptic plasticity of adult-born hippocampal granule cells. J Neurosci. 2008;28:1374–1384.

Sahay A , Hen R. Adult hippocampal neurogenesis in depression. Nat Neurosci. 2007;10:1110–1115.

DeCarolis NA , Eisch AJ. Hippocampal neurogenesis as a target for the treatment of mental illness: a critical evaluation. Neuropharmacology. 2010;58:884–893.

Kitayama N , Vaccarino V , Kutner M , . Magnetic resonance imaging (MRI) measurement of hippocampal volume in posttraumatic stress disorder: a meta-analysis. J Affect Disord. 2005;88:79–86.

Wignall EL , Dickson JM , Vaughan P , . Smaller hippocampal volume in patients with recentonset posttraumatic stress disorder. Biol Psychiatry. 2004;56:832–836.

Bonne O , Brandes D , Gilboa A , . Longitudinal MRI study of hippocampal volume in trauma survivors with PTSD. Am J Psychiatry. 2001;158:1248–1251.

Fennema-Notestine C , Stein MB , Kennedy CM , . Brain morphometry in female victims of intimate partner violence with and without posttraumatic stress disorder. Biol Psychiatry. 2002;52:1089–1101.

Carrion VG , Weems CF , Eliez S , . Attenuation of frontal asymmetry in pediatric posttraumatic stress disorder. Biol Psychiatry. 2001;50:943–951.

De Bellis MD , Hall J , Boring AM , . A pilot longitudinal study of hippocampal volumes in pediatric maltreatment-related posttraumatic stress disorder. Biol Psychiatry. 2001;50:305–309.

Bremner JD , Narayan M , Staib LH , . Neural correlates of memories of childhood sexual abuse in women with and without posttraumatic stress disorder. Am J Psychiatry. 1999;156:1787–1795.

Bremner JD , Vythilingam M , Vermetten E , . Neural correlates of declarative memory for emotionally valenced words in women with posttraumatic stress disorder related to early childhood sexual abuse. Biol Psychiatry. 2003;53:879–889.

Shin LM , Shin PS , Heckers S , . Hippocampal function in posttraumatic stress disorder. Hippocampus. 2004;14:292–300.

Berger W , Mendlowicz MV , Marques-Portella C , . Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: a systematic review. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33:169–180.

Bisson J , Andrew M. Psychological treatment of post-traumatic stress disorder (PTSD). Cochrane Database Syst Rev. 2005:CD003388.

Stein DJ , Ipser JC , Seedat S. Pharmacotherapy for post traumatic stress disorder (PTSD). Cochrane Database Syst Rev. 2006:CD002795.

Davidson J , Baldwin D , Stein DJ , . Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial. Arch Gen Psychiatry. 2006;63:1158–1165.

Walderhaug E , Kasserman S , Aikins D , . Effects of duloxetine in treatment-refractory men with posttraumatic stress disorder. Pharmacopsychiatry. 2010;43:45–49.

Margoob MA , Ali Z , Andrade C. Efficacy of ECT in chronic, severe, antidepressant- and CBT-refractory PTSD: an open, prospective study. Brain Stimul. 2010;3:28–35.

Ballenger JC , Davidson JR , Lecrubier Y , . Consensus statement update on posttraumatic stress disorder from the international consensus group on depression and anxiety. J Clin Psychiatry. 2004;65:55–62.

Marshall RD , Pierce D. Implications of recent findings in posttraumatic stress disorder and the role of pharmacotherapy. Harv Rev Psychiatry. 2000;7:247–256.

Hetrick SE , Purcell R , Garner B , . Combined pharmacotherapy and psychological therapies for post traumatic stress disorder (PTSD). Cochrane Database Syst Rev. 2010:CD007316.

Parikh SV , Segal ZV , Grigoriadis S , . Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. II. Psychotherapy alone or in combination with antidepressant medication. J Affect Disord. 2009;117:S15–S25.

Mitte K. Meta-analysis of cognitive-behavioral treatments for generalized anxiety disorder: a comparison with pharmacotherapy. Psychol Bull. 2005;131:785–795.

Rief W , Trenkamp S , Auer C , . Cognitive behavior therapy in panic disorder and comorbid major depression. A naturalistic study. Psychother Psychosom. 2000;69:70–78.

van Balkom AJ , van Boeijen CA , Boeke AJ , . Comorbid depression, but not comorbid anxiety disorders, predicts poor outcome in anxiety disorders. Depress Anxiety. 2008;25:408–415.

Hofmann SG , Smits JA. Cognitive-behavioral therapy for adult anxiety disorders: a meta-analysis of randomized placebo-controlled trials. J Clin Psychiatry. 2008;69:621–632.

Chambless DL , Tran GQ , Glass CR. Predictors of response to cognitive-behavioral group therapy for social phobia. J Anxiety Disord. 1997;11:221–240.

Acarturk C , Cuijpers P , van Straten A , . Psychological treatment of social anxiety disorder: a meta-analysis. Psychol Med. 2009;39:241–254.

Moscovitch DA , Hofmann SG , Suvak MK , . Mediation of changes in anxiety and depression during treatment of social phobia. J Consult Clin Psychol. 2005;73:945–952.

Steketee G , Chambless DL , Tran GQ. Effects of axis I and II comorbidity on behavior therapy outcome for obsessive-compulsive disorder and agoraphobia. Compr Psychiatry. 2001;42:76–86.

Overbeek T , Schruers K , Vermetten E , . Comorbidity of obsessive-compulsive disorder and depression: prevalence, symptom severity, and treatment effect. J Clin Psychiatry. 2002;63:1106–1112.

Brent D , Emslie G , Clarke G , . Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. JAMA. 2008;299:901–913.

March J , Silva S , Petrycki S , . Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents with Depression Study (TADS) randomized controlled trial. JAMA. 2004;292:807–820.

Goodyer I , Dubicka B , Wilkinson P , . Selective serotonin reuptake inhibitors (SSRIs) and routine specialist care with and without cognitive behaviour therapy in adolescents with major depression: randomised controlled trial. BMJ. 2007;335:142.

Kovacs M , Gatsonis C , Paulauskas SL , . Depressive disorders in childhood. IV. A longitudinal study of comorbidity with and risk for anxiety disorders. Arch Gen Psychiatry. 1989;46:776–782.

Lewinsohn PM , Clarke GN , Seeley JR , . Major depression in community adolescents: age at onset, episode duration, and time to recurrence. J Am Acad Child Adolesc Psychiatry. 1994;33:809–818.

Rao U , Ryan ND , Birmaher B , . Unipolar depression in adolescents: clinical outcome in adulthood. J Am Acad Child Adolesc Psychiatry. 1995;34:566–578.

Sanford M , Szatmari P , Spinner M , . Predicting the one-year course of adolescent major depression. J Am Acad Child Adolesc Psychiatry. 1995;34:1618–1628.

Gould MS , Greenberg T , Velting DM , . Youth suicide risk and preventive interventions: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry. 2003;42:386–405.

Bridge JA , Goldstein TR , Brent DA. Adolescent suicide and suicidal behavior. J Child Psychol Psychiatry. 2006;47:372–394.

Kendall PC , Kortlander E , Chansky TE , . Comorbidity of anxiety and depression in youth: treatment implications. J Consult Clin Psychol. 1992;60:869–880.

Young JF , Mufson L , Davies M. Impact of comorbid anxiety in an effectiveness study of interpersonal psychotherapy for depressed adolescents. J Am Acad Child Adolesc Psychiatry. 2006;45:904–912.

Brent DA , Kolko DJ , Birmaher B , . Predictors of treatment efficacy in a clinical trial of three psychosocial treatments for adolescent depression. J Am Acad Child Adolesc Psychiatry. 1998;37:906–914.

Rohde P , Clarke GN , Lewinsohn PM , . Impact of comorbidity on a cognitive-behavioral group treatment for adolescent depression. J Am Acad Child Adolesc Psychiatry. 2001;40:795–802.

Curry J , Rohde P , Simons A , . Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS). J Am Acad Child Adolesc Psychiatry. 2006;45:1427–1439.

Emslie GJ , Mayes T , Porta G , . Treatment of Resistant Depression in Adolescents (TORDIA): week 24 outcomes. Am J Psychiatry. 2010;167:782–791.

Asarnow JR , Emslie G , Clarke G , . Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment response. J Am Acad Child Adolesc Psychiatry. 2009;48:330–339.